MedTrace Logo

Conservative Surgery in Treating Patients With Low-Risk Stage IA2 or IB1 Cervical Cancer

NCT01048853 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 137

Last updated 2026-01-07

Study results available
· View outcomes & findings →

Summary

This clinical trial studies conservative surgery in treating patients with low-risk stage IA2 or IB1 cervical cancer. Conservative surgery is a less invasive type of surgery for early stage cervical cancer and may have fewer side effects and improve recovery.

Conditions

  • Cervical Adenocarcinoma
  • Cervical Squamous Cell Carcinoma, Not Otherwise Specified
  • Stage IA2 Cervical Cancer AJCC v6 and v7
  • Stage IB1 Cervical Cancer AJCC v6 and v7

Interventions

PROCEDURE

Lymph Node Mapping

Undergo lymphatic mapping with sentinel lymph node biopsy

OTHER

Quality-of-Life Assessment

Ancillary studies

PROCEDURE

Salpingo-Oophorectomy

Undergo hysterectomy with or without salpingo-oophorectomy

PROCEDURE

Sentinel Lymph Node Biopsy

Undergo lymphatic mapping with sentinel lymph node biopsy

PROCEDURE

Therapeutic Conventional Surgery

Undergo hysterectomy with or without salpingo-oophorectomy

Sponsors & Collaborators

  • National Cancer Institute (NCI)

    collaborator NIH

  • M.D. Anderson Cancer Center

    lead OTHER

Principal Investigators

  • Kathleen M Schmeler · M.D. Anderson Cancer Center

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-04-15
Primary Completion
2024-12-31
Completion
2025-12-05
FDA Drug
Yes

Countries

  • United States
  • Argentina
  • Australia
  • Brazil
  • Colombia
  • Mexico
  • Peru
  • Thailand

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01048853 on ClinicalTrials.gov